A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROG... [J Pediatr. 1964]

THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS. [J Pediatr. 1964]
THE USE OF N-ACETYLCYSTEINE IN THE TREATMENT OF CYSTIC FIBROSIS.
REAS HW. J Pediatr. 1964 Oct; 65:542-57.
BOTRYOMYCOSIS, A COMPLICATION CYSTIC FIBROSIS. REPORT OF 7 CASES. [J Pediatr. 1964]
BOTRYOMYCOSIS, A COMPLICATION CYSTIC FIBROSIS. REPORT OF 7 CASES.
KATZNELSEN D, VAWTER GF, FOLEY GE, SHWACHMAN H. J Pediatr. 1964 Oct; 65:525-39.
A THERAPEUTIC REGIMEN FOR PATIENTS WITH CYSTIC FIBROSIS. [J Pediatr. 1964]
A THERAPEUTIC REGIMEN FOR PATIENTS WITH CYSTIC FIBROSIS.
MATTHEWS LW, DOERSHUK CF, WISE M, EDDY G, NUDELMAN H, SPECTOR S. J Pediatr. 1964 Oct; 65:558-75.
Review [Bacterial infections of the lungs in mucoviscidosis patients] [MMW Fortschr Med. 2005]
Review [Bacterial infections of the lungs in mucoviscidosis patients]
Hogardt M, Heesemann J. MMW Fortschr Med. 2005 Jan 27; 147(4):38-40.
Review Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis. [Drugs. 2003]
Review Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
Cheer SM, Waugh J, Noble S. Drugs. 2003; 63(22):2501-20.

Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. [J Pediatr. 2009]
Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.
Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, Ramsey BW, Inhaled Tobramycin in Young Children Study Group, Cystic Fibrosis Foundation Therapeutics Development Network. J Pediatr. 2009 Feb; 154(2):183-8. Epub 2008 Sep 25.
CYSTIC FIBROSIS OF PANCREAS. [Br Med J. 1965]
CYSTIC FIBROSIS OF PANCREAS.
BEVERIDGE GW, LAWSON AA. Br Med J. 1965 Jul 10; 2(5453):58-9.
Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity? [Thorax. 1998]
Quality of life in patients with cystic fibrosis and their parents: what is important besides disease severity?
Staab D, Wenninger K, Gebert N, Rupprath K, Bisson S, Trettin M, Paul KD, Keller KM, Wahn U. Thorax. 1998 Sep; 53(9):727-31.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC F...
A 5 YEAR CLINICAL EVALUATION OF A THERAPEUTIC PROGRAM FOR PATIENTS WITH CYSTIC FIBROSIS.
J Pediatr. 1964 Nov ;65:677-93.

PubMed
Norethandrolone in children with and without cystic fibrosis of the pancreas.
Norethandrolone in children with and without cystic fibrosis of the pancreas.
Ill Med J. 1961 Sep ;120:156-61.

PubMed
Negative sweat tests and cystic fibrosis.
Negative sweat tests and cystic fibrosis.
Arch Dis Child. 1975 Jun ;50(6):463-6.

PubMed
Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of a...
Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period.
Pediatrics. 1970 Sep ;46(3):335-43.

PubMed
LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH CYSTIC FIBROSIS.
LONG-TERM THERAPY WITH OXACILLIN IN PATIENTS WITH CYSTIC FIBROSIS.
Antimicrob Agents Chemother (Bethesda). 1963 ;161:237-42.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed